Linomide
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Objective: To determine whether linomide (roquinimex) is better than placebo in slowing the time to confirmed clinical worsening…
Objective: To determine the safety and efficacy of roquinimex (linomide) in the management of relapsing-remitting and secondary…
In previous studies, we have demonstrated that androgen ablation-induced growth inhibition of androgen-responsive PC-82 and A-2…
Prostate cancer is the most commonly diagnosed neoplasm and the second leading cause of male death in this country. Multiple…
Linomide is a p.o. active antiangiogenic agent that has been demonstrated to be effective in suppressing the in vivo growth of…
Linomide (quinoline-3-carboxamide) is a synthetic immunomodulator that increases the natural killer cell activity. We previously…
In a number of experimental systems in which lymphocyte depletion was induced by apoptosis-inducing manipulations, no apoptotic…
Linomide is a synthetic immunomodulator that enhances natural killer cell activity and significantly activates several…
Linomide (N-phenylmethyl-1,2-dihydro-4-hydroxyl-1-methyl-2-oxoquinoline-3-carboxa mide) has a reproducible in vivo antitumor…